With the analysis among 3,808 patents, we discovered top 446 key players by total patent application. Astellas Pharma, Inc., Amgen, Inc., Ganymed Pharmaceuticals AG are dominant in this area. They take 7.22% of the total patent filing.
Tokyo-to, Japan
Patent: 108
California, United States
Patent: 93
Ganymed Pharmaceuticals AG
Rheinland-Pfalz, Germany
Patent: 69
Basel-Stadt, Switzerland
Patent: 64
Immatics Biotechnologies GmbH
Baden-Württemberg, Germany
Patent: 53
California, United States
Patent: 46
Indiana, United States
Patent: 45
F. Hoffmann-La Roche Ltd.
Guangzhou Kangliming Biosciences Technology Co. Ltd.
Guangdong Sheng, China
Patent: 35
New York, United States
Patent: 33
With the analysis among 187 patents, we discovered top 40 start-ups by total patent application. Guangzhou Kangliming Biosciences Technology Co. Ltd., Institut National de la Santé et de la Recherche Médicale, AnchorDX Corp. are active in this area.
Guangzhou Kangliming Biosciences Technology Co. Ltd.
Guangdong Sheng, China
Patent: 35
Institut National de la Santé et de la Recherche Médicale
Guangdong Sheng, China
Patent: 11
California, United States
Patent: 10
California, United States
Patent: 6
Beijing Shi, China
Patent: 6
LISCure Bioscience Co. Ltd.
With the analysis among related 4,267 patents applied in the last 5 years. We discover 500 most active companies in this area. The fast-growing West China Hospital of Sichuan University, Amgen, Inc., Cancer Hospital Chinese Academy of Medical Sciences take 5.09% of patent filing during this period.
West China Hospital of Sichuan University
California, United States
Patent: 79
Cancer Hospital Chinese Academy of Medical Sciences
Beijing Shi, China
Patent: 54
Tokyo-to, Japan
Patent: 53
Dana-Farber Cancer Institute, Inc.
Massachusetts, United States
Patent: 46
Basel-Stadt, Switzerland
Patent: 40
China Pharmaceutical University
Jiangsu Sheng, China
Patent: 37
Guangzhou Kangliming Biosciences Technology Co. Ltd.
Guangdong Sheng, China
Patent: 35
Immatics Biotechnologies GmbH
Baden-Württemberg, Germany
Patent: 32
Guangdong Sheng, China
Patent: 25
With the analysis among related 4,267 patents in last 5 years, we discover 320 new entrants. Guangzhou Kangliming Biosciences Technology Co. Ltd., Oncobix Co., Ltd., Chengdu West China Precision Medicine Industry Technology Research Institute Co., Ltd. are the most active new entrants in this area.
Guangzhou Kangliming Biosciences Technology Co. Ltd.
Guangdong Sheng, China
Patent: 35
Chengdu West China Precision Medicine Industry Technology Research Institute Co., Ltd.
Sichuan Sheng, China
Patent: 22
Beijing Yangshen Bio-Information Technology Co., Ltd.
Beijing Shi, China
Patent: 20
Les Laboratoires Servier SAS
Nanjing Tengchen Biotechnology Co., Ltd.
Jiangsu Sheng, China
Patent: 15
Biochain Beijing Science & Technology, Inc.
Beijing Shi, China
Patent: 15
Xiangya Hospital of Central South University
Hunan Sheng, China
Patent: 13
Henan Sheng, China
Patent: 13
With the analysis among 1,965 patents, we discovered top 270 universities and scientific research institutions by total patent application. The Johannes Gutenberg University of Mainz, China Pharmaceutical University, Sun Yat-Sen University are dominant in this area. They take 6.26% of the total patent filing.
The Johannes Gutenberg University of Mainz
Rheinland-Pfalz, Germany
Patent: 42
China Pharmaceutical University
Jiangsu Sheng, China
Patent: 40
Guangdong Sheng, China
Patent: 27
Zhejiang University of Technology
Zhejiang Sheng, China
Patent: 25
The Johns Hopkins University
Sichuan Sheng, China
Patent: 22
Shanghai Institute of Materia Medica Chinese Academy of Sciences
Shanghai Shi, China
Patent: 19
Massachusetts, United States
Patent: 18
Shandong Sheng, China
Patent: 17
Shanghai Shi, China
Patent: 16